These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1833211)

  • 1. Polymorphonuclear leukocyte-dependent modulation of platelet function: effect of cloricromene.
    Zatta A; Prosdocimi M; Bazzoni G; Dejana E; Del Maschio A
    Eur J Pharmacol; 1991 May; 198(1):97-100. PubMed ID: 1833211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
    Evangelista V; Rajtar G; de Gaetano G; White JG; Cerletti C
    Blood; 1991 Jun; 77(11):2379-88. PubMed ID: 1645603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcellular metabolism of arachidonic acid: increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes.
    Maugeri N; Evangelista V; Piccardoni P; Dell'Elba G; Celardo A; de Gaetano G; Cerletti C
    Blood; 1992 Jul; 80(2):447-51. PubMed ID: 1627802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endoperoxides/TxA2 analogue, U46619, inhibits human polymorphonuclear leukocyte function.
    Rotondo S; Celardo A; Evangelista V; Cerletti C
    J Leukoc Biol; 1995 Jan; 57(1):72-9. PubMed ID: 7829974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin inhibits neutrophil-induced platelet activation via cathepsin G.
    Ferrer-Lopez P; Renesto P; Prevost MC; Gounon P; Chignard M
    J Lab Clin Med; 1992 Mar; 119(3):231-9. PubMed ID: 1541873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of human platelets and leukocytes in modulation of vascular tone.
    Kaul S; Waack BJ; Padgett RC; Brooks RM; Heistad DD
    Am J Physiol; 1994 May; 266(5 Pt 2):H1706-14. PubMed ID: 8203570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation.
    Rajtar G; Marchi E; de Gaetano G; Cerletti C
    Biochem Pharmacol; 1993 Sep; 46(5):958-60. PubMed ID: 8373448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
    Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation induced by a stable analogue of endoperoxides (U46619).
    Zatta A; Prosdocimi M
    Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro inhibition of human polymorphonuclear cell function by cloricromene.
    Bertocchi F; Breviario F; Proserpio P; Wang JM; Ghezzi P; Travagli RA; Prosdocimi M; Dejana E
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):697-703. PubMed ID: 2549432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin-mediated cell-cell adhesion.
    Evangelista V; Piccardoni P; White JG; de Gaetano G; Cerletti C
    Blood; 1993 Jun; 81(11):2947-57. PubMed ID: 7684621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M
    Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by human leukocyte elastase of neutrophil-mediated platelet activation.
    Renesto P; Balloy V; Chignard M
    Eur J Pharmacol; 1993 Aug; 248(2):151-5. PubMed ID: 8223961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
    Renesto P; Chignard M
    J Immunol; 1991 Apr; 146(7):2305-9. PubMed ID: 2005399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
    J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation induced by the endoperoxide analogue U46619 is inhibited by polymorphonuclear leukocyte ADPase activity.
    Zatta A; Pandolfo L; Caparrotta L; Prosdocimi M; Dejana E; Del Maschio A
    Arterioscler Thromb; 1993 May; 13(5):696-701. PubMed ID: 8485121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation.
    Renesto P; Chignard M
    Blood; 1993 Jul; 82(1):139-44. PubMed ID: 8324217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloricromene inhibits the activation of human platelets by ADP alone or in combination with adrenaline.
    Del Maschio A; Bazzoni G; Zatta A; Chen ZM; Dejana E; Prosdocimi M
    Eur J Pharmacol; 1990 Oct; 187(3):541-5. PubMed ID: 2073928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.